HTA study of antidepressants for depression in dementia - a definitive multicentre pragmatic RCT of clinical and cost effectiveness.

Trial Profile

HTA study of antidepressants for depression in dementia - a definitive multicentre pragmatic RCT of clinical and cost effectiveness.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2013

At a glance

  • Drugs Mirtazapine (Primary) ; Sertraline (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Acronyms HTA-SADD
  • Most Recent Events

    • 10 Aug 2013 Accrual to date is 65% according to United Kingdom Clinical Research Network.
    • 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
    • 20 Jul 2011 Primary endpoint 'Cornell-Scale-for-Depression-in-Dementia' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top